ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Titan Medical Inc

Titan Medical Inc (TMDI)

0.14
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.14
Bid
0.1333
Ask
0.1367
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.14
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
114,040,000
Dividend Yield
-
PE Ratio
6.23
Earnings Per Share (EPS)
0.06
Revenue
17.63M
Net Profit
6.95M

About Titan Medical Inc

Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system. Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Sector
Ortho,prosth,surg Appl,suply
Industry
Business Services, Nec
Website
Headquarters
Toronto, Ontario, Can
Founded
2008

TMDI Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TMDI - Frequently Asked Questions (FAQ)

What is the current Titan Medical share price?
The current share price of Titan Medical is $ 0.14
How many Titan Medical shares are in issue?
Titan Medical has 114,040,000 shares in issue
What is the market cap of Titan Medical?
The market capitalisation of Titan Medical is USD 15.97M
What is the 1 year trading range for Titan Medical share price?
Titan Medical has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Titan Medical?
The price to earnings ratio of Titan Medical is 6.23
What is the cash to sales ratio of Titan Medical?
The cash to sales ratio of Titan Medical is 2.46
What is the reporting currency for Titan Medical?
Titan Medical reports financial results in USD
What is the latest annual turnover for Titan Medical?
The latest annual turnover of Titan Medical is USD 17.63M
What is the latest annual profit for Titan Medical?
The latest annual profit of Titan Medical is USD 6.95M
What is the registered address of Titan Medical?
The registered address for Titan Medical is 293, LESMILL ROAD, TORONTO, ONTARIO, M3B 2V1
What is the Titan Medical website address?
The website address for Titan Medical is www.conavi.com
Which industry sector does Titan Medical operate in?
Titan Medical operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CEROCERo Therapeutics Holdings Inc
$ 20.584
(199.71%)
46.8M
RBNERobin Energy Ltd
$ 12.85
(132.79%)
33.88M
ACXPAcurx Pharmaceuticals Inc
$ 0.6651
(116.57%)
288.71M
VERVVerve Therapeutics Inc
$ 11.215
(78.87%)
71.05M
EYENEyenovia Inc
$ 4.95
(66.67%)
10.24M
SDSTStardust Power Inc
$ 0.184
(-52.61%)
32.37M
SHOTWSafety Shot Inc
$ 0.015
(-49.66%)
5.65k
RUNSunrun Inc
$ 5.805
(-39.78%)
87.28M
SEDGSolarEdge Technologies Inc
$ 15.7901
(-34.15%)
26.26M
ADILAdial Pharmaceuticals Inc
$ 0.2346
(-27.84%)
5.37M
PCSAProcessa Pharmaceuticals Inc
$ 0.2423
(7.64%)
507.68M
ACXPAcurx Pharmaceuticals Inc
$ 0.6651
(116.57%)
288.71M
GNLNGreenlane Holdings Inc
$ 0.0107
(-13.71%)
269.41M
HCTIHealthcare Triangle Inc
$ 0.0224
(-15.15%)
216.66M
LCIDLucid Group Inc
$ 2.16
(0.47%)
109.04M

TMDI Discussion

View Posts
SPORT19 SPORT19 1 month ago
"Bloom Burton Securities Inc. acted as sole and exclusive agent for the Offering."
Right out of the Titan playbook!
DILUTION, DILUTION, DILUTION!!


👍️0
Frankestin Frankestin 1 month ago
https://www.globenewswire.com/news-release/2025/04/23/3066428/0/en/Conavi-Medical-Corp-Announces-Closing-of-20M-Public-Offering.html
Has anyone finally covered? Hard to believe there is an investor or the volumes to cover 32/50 million shares.
👍️0
Frtysvn Frtysvn 1 month ago
Thank you for sharing.
👍️0
Frankestin Frankestin 1 month ago
👍️0
Frankestin Frankestin 2 months ago

👍️0
Adrock Adrock 3 months ago
Technology was scoopable we all though that, management lied, sold us out and mismanaged period!
👍 1
Acehole Acehole 3 months ago
Nice find. You should buy shares now while they’re still cheap. Scoooop those shares.
👍️0
Adrock Adrock 4 months ago
https://www.linkedin.com/posts/stevegbell_surgicalrobotics-roboticsurgery-singleport-ugcPost-7300480903288426498-yoEX?utm_source=share&utm_medium=member_ios&rcm=ACoAABZO5dQBEIQKK7jkejvP-4uxaZGl2_Y2sF4
👍️0
Frankestin Frankestin 4 months ago
What do you mean by ‘ours’?
👍️0
SPORT19 SPORT19 4 months ago
I think 2025 is going to be our year!
👍️0
Frankestin Frankestin 4 months ago
👍️0
Magnetics Magnetics 4 months ago
Hi Geo. I hope you're doing well.
I havent been on this site since the ending fall out w titan. I guess our old board is gone. Nothing like sensorship and silencing their investors.. sickening. I'm really only able to reply because of an old message from you that was in my inbox here. I was just wondering if you guys are still posting anywhere about titan or whatever the loser name is now? Or, anything new.. lawsuits to join..? If you're interested, feel free to email me direct at magnetics101@yahoo.com . Thanks and take care.
👍️0
BelizeMe BelizeMe 4 months ago
Déjà vu… Dilute dilute dilute

BelizeMe



👍️0
Frankestin Frankestin 5 months ago
déjà-vu…. Also, the last time you talked about it here, it was around $15, right?
👍️0
SPORT19 SPORT19 5 months ago
RBOT did a 1-30 RS last year which landed the stock at around $5/share
HOWEVER unlike POS Titan RBOT has steadily climbed from there to now approaching $20/ share!


👍️0
Frankestin Frankestin 6 months ago
I'm waiting for Giovinazzo and Steiner to be of some use!
But I don't have much hope
👍️0
renaissance1 renaissance1 6 months ago
What are we looking at here buddy? Thanks in advance for any information.
👍️0
Frankestin Frankestin 6 months ago
👍️0
renaissance1 renaissance1 7 months ago
It’s a shame most of us got totally whipped out. Oh well. Win some. Loose some.
👍️0
Frankestin Frankestin 7 months ago
cruel! but who knows who is joking?
👍️0
Frankestin Frankestin 8 months ago

this too! DATE FILED 2024-04-10
Why do it?
What a steal!
👍️0
Frankestin Frankestin 8 months ago


what a steal!
👍️0
Geo2014 Geo2014 8 months ago
CNVI
👍️0
SPORT19 SPORT19 8 months ago
What’s the new ticker ?
👍️0
Adrock Adrock 8 months ago
SUUUUUUUUUUUUUUem!
👍️0
SPORT19 SPORT19 8 months ago
In other single port robotic news RBOT did a 1 for 30 RS a number of months ago….
The RS brought it to around $5 however unlike TMDI the stock stayed stable and has continued to rise to over $8 today.

Worth watching IMO

👍️0
SPORT19 SPORT19 8 months ago
1 for 25 reverse split
👍️0
Renee Renee 8 months ago
TMDIF: effective Oct. 16,2024: Titan Medical has completed an amalgamation involving Conavi Medical Inc. Titan Medical and a wholly-owned subsidiary of the Company, 1000824255 Ontario Inc., which resulted in the reverse takeover of the Company by Conavi. Following completion of the Amalgamation, the Company has been renamed Conavi Medical Corp. Immediately prior to the closing of the Amalgamation, the Shares of the Company were consolidated on a 1-for-25 basis.

https://otce.finra.org/otce/dailyList?viewType=Deletions
👍️0
Adrock Adrock 8 months ago
RECOUNT RECOUNT
👍️0
Geo2014 Geo2014 8 months ago
I think voting was done on Dominion machines.
👍️0
Geo2014 Geo2014 8 months ago
Will do brutha! I lost on Verb too. Cuin2 is/was the biggest f’n hack pumper!



F him and his Blue Ocean Strategy!
👍️0
SPORT19 SPORT19 8 months ago
News out!!!!

https://ir.titanmedicalinc.com/news-events/press-releases/detail/423/titan-announces-resignations-of-directors
👍️0
Frankestin Frankestin 9 months ago
"everything must change so that everything stays the same"

👍️0
SPORT19 SPORT19 9 months ago
At least the directors got fired…..
👍️0
SPORT19 SPORT19 9 months ago
Once again Titan shareholders give management what they want….

Never worked a single time before….

Congratulations on locking in your losses people….
👍️0
SPORT19 SPORT19 9 months ago
https://ir.titanmedicalinc.com/news-events/press-releases/detail/422/titan-reports-voting-results-from-2023-annual-general-and
👍️0
Magnetics Magnetics 9 months ago
Thanks for your message Geo! I also got burned on VERB.. Please try to reach out to me again if you hear anything new. I've never been to stock twits but, maybe I should.. I thought that was where all the smart titan investors went. To Scoopsville...
👍️0
Geo2014 Geo2014 9 months ago
Mag, we may go after’em. If you have an account on StockTwits, go read through some of our latest posts. A few of us are trying to rally the troops. This is what gives us a glimmer of hope…

https://www.reuters.com/legal/judge-rules-that-jj-owes-auris-1-bln-related-2019-robot-deal-2024-09-04/
👍️0
Jbuffett Jbuffett 9 months ago
I can't believe the same folks are still hanging in to titan. If you haven't sold out... It's over... Time to move on to another company. Check out Monogram robotics. Ortho robotics is where the market is heading...
👍️0
bobbysixty bobbysixty 9 months ago
Agree with you. Worst financial mistake of a lifetime. I regret hearing about this company and will never invest in a penny again.
👍️0
Magnetics Magnetics 9 months ago
Checking in probably one last time here as I've lost over 150k on this.. worst experience of my life.. even more painful that it went on for 12 plus years of pain. I'm writing here one last time hoping that no one is voting yes on this.. and if you do you might as well vote for Kamala as well. After losing 150k + and still having all those shares that have been reverse split who knows how many times I'm left with a total of just 1,500 or so in stock.. a yes vote will bring even less. Only one getting paid will be the company directors on both side and lawyers.. please vote no and shut these scammers down! And I won't be attending the conference call because there's nothing to hear. It's been fun communicating with some of you over the years here. Big lesson learned here. And that this place is full of evil people trying to scam all day everyday
👍️0
Frankestin Frankestin 9 months ago

what a steal!
https://titanmedicalinc.com/enos/
https://titanmedicalinc.com/videos/
https://titanmedicalinc.com/technology/
https://titanmedicalinc.com/wp-content/uploads/2022/10/Titan-Medical-White-Paper-Supporting-Single-Access-RAS-FINAL.pdf 🤮
simply thieves!
👍️0
renaissance1 renaissance1 9 months ago
Can you please explain why you are recommending a no vote? I don’t think this company as it stands will be able to continue if they don’t do something. but in all honesty I haven’t read the circular yet so I don’t really have an educated opinion as of today. But I appreciate any info you are willing to provide. Thanks in advance and good luck. We may need it. Lol.
👍️0
Adrock Adrock 9 months ago
Withhold!!!
👍️0
SPORT19 SPORT19 9 months ago
VOTE NO!!!!

https://ir.titanmedicalinc.com/news-events/press-releases/detail/414/titan-announces-filing-of-the-management-information
👍️0
Pharmmoney Pharmmoney 9 months ago
What’s going on with the voting ?
👍️0
Frankestin Frankestin 10 months ago
👍️0
Adrock Adrock 10 months ago
https://www.medicaldevice-network.com/data-insights/titan-medical-gets-grant-for-method-for-ergonomic-positioning-of-robotic-surgery-input-device/
👍️0
SPORT19 SPORT19 10 months ago
No R&D……where did all those MILLIONS go since 12/31/23?????

VOTE NO!!!!!!!!
👍️0
FISH21049 FISH21049 10 months ago
Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
Titan Medical Inc.
Thu, Aug 15, 2024, 11:32 AM CDT6 min read\

TORONTO, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three and six months ended June 30, 2024.

Recent Activities in Q2 2024:

On May 29, 2024, the Company announced an amendment to the timeframe under which certain closing conditions must be met in the amalgamation agreement dated March 17, 2024 with Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) (the “Amalgamation Agreement”).

On July 5, 2024, the Company announced the second amendment to the timeframe under which certain conditions must be met in the Amalgamation Agreement and announced the Company was seeking an additional extension with the Toronto Stock Exchange (“TSX”) to hold its Annual General and Special Meeting of Shareholders (the “Titan AGM”) on or before September 30, 2024.

On August 14, 2024, the Company announced the third amendment to alter certain closing conditions that must be met in the Amalgamation Agreement.

extending the Outside Date (as such term is defined in the Amalgamation Agreement) for completion of the Proposed Transaction to October 10, 2024;

extending the date by which the Concurrent Financing (as such term is defined in the Amalgamation Agreement) must be committed to September 3, 2024;

reducing the minimum aggregate size of the Concurrent Financing (as such term is defined in the Amalgamation Agreement) from $15 million to $7.5 million;

extending the date by which Conavi financial statements must be completed to August 23, 2024;

reducing the minimum net cash Titan must have at the Effective Time (as such term is defined in this Amalgamation Agreement) from US$5 million to US$2 million;

extending the targeted date by which the information circular for the Titan AGM must be mailed to shareholders to September 3, 2024;

extending the targeted date by which the Titan AGM must be held to September 30, 2024;

extending the targeted date by which the information circular for the Conavi annual general meeting must be mailed to shareholders to September 3, 2024; and

extending the targeted date by which the Conavi annual general meeting must be held to September 30, 2024.

Financial Highlights:

As of June 30, 2024, Titan had cash of $3.9 million, compared to $7.5 million as at December 31, 2023. Working capital was $3.3 million as of June 30, 2024, compared to $5.5 million as at December 31, 2023.

Research and development (“R&D”) expenses were nil for the three months ended June 30, 2024 compared to $0.4 million for the three months ended June 30, 2023. R&D expenses were recovery of $0.1 million for the six months ended June 30, 2024 compared to $0.8 million for the six months ended June 30, 2023.

In the three and six months ended June 30, 2023, the Company implemented cost-cutting measures that significantly reduced R&D expenses. In the six months ended June 30, 2024, R&D expense recovery of $0.1 million is attributed to cancellation of stock options and restricted share units related to R&D personnel.

General and administrative (“G&A”) expenses were $1.1 million and $2.0 million for the three and six months ended June 30, 2024 compared to $4.3 million and $6.6 million for the comparative periods ended June 30, 2023. The decrease in G&A expenses in the current period is related to the cost-cutting measures implemented in Q2, 2023. In 2023, G&A expenses included severance charges of $1.4M, transaction costs of $1.5M, and increased stock-based compensation, offset by reduction in costs due to cost-cutting measures.

The Company’s interim consolidated financial statements and management discussions and analysis for the period ended June 30, 2024 are available at www.sedarplus.ca. The Company’s condensed interim consolidated financial statements have been prepared by management and reviewed by the Company’s auditors.

About Titan Medical

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ontario, has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property while pursuing the completion of its agreed upon Transaction with Conavi Medical Inc.

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Titan’s future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to: Titan evaluating new opportunities to further develop and license its intellectual property, the payment of future settlement amounts, the delivery of materials to Titan, and the completion of the merger with Conavi.

These forward-looking statements reflect management’s current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Titan’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Titan’s ability to retain key personnel; its ability to execute on its business plans and strategies; its ability to continue to license some or all its intellectual property to third parties and receive any material consideration and other factors listed in the “Risk Factors” section of Titan’s Annual Information Form for the fiscal year ended December 31, 2023 (which may be viewed at www.sedarplus.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements.

Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Titan has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Titan cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Titan expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements.

Contact
Chien Huang
Chief Financial Officer
investors@titanmedicalinc.com
👍️0

Your Recent History

Delayed Upgrade Clock